June 30, 2023
The U.S. Food and Drug Administration (FDA) has recently granted approval to Lantidra, an ...
February 9, 2023
Autologous CAR-T cell therapy has revolutionized the way some cancers are treated, offering ...
January 5, 2023
– Gustavo Mahler hired as the Chief Executive Officer of Ncardia and Cellistic, and will join ...
September 20, 2022
April 27, 2022
– Collaboration combines Quell’s pioneering autologous multi-modular Treg cell therapy ...
April 18, 2022
Ncardia launches CellisticTM, the only iPSC-based cell therapy process development & ...
